Clinical Trial Update: Clinical Applicability of pCASL as a Substitute for FDG-PET in MCI and SCD Patients

View source ↗

Summary

This completed clinical trial assesses whether arterial spin labeling (pCASL) can substitute FDG-PET imaging in individuals with mild cognitive impairment and s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Subjective Cognitive Decline

Snippet

Sponsor: University of Milano Bicocca | Conditions: Mild Cognitive Impairment, Subjective Cognitive Decline | Status: COMPLETED